Evidence map›Paper›PMID 37590133›Full record

ArticleCell reports2023

A planar polarized MYO6-DOCK7-RAC1 axis promotes tissue fluidification in mammary epithelia.

Luca Menin, Janine Weber, Stefano Villa, Emanuele Martini, Elena Maspero, Carlos A Niño, Valeria Cancila, Alessandro Poli, Paolo Maiuri, Andrea Palamidessi and 7 more

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Identification of PKN2 and MOB4 as Coordinators of Collective Cell Migration.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  4. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Luca MeninIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Janine WeberIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Stefano VillaDipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Segrate, Italy.
Emanuele MartiniIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Elena MasperoIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Carlos A NiñoIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Valeria CancilaHuman Pathology Section, Department of Health Sciences, University of Palermo School of Medicine, Palermo, Italy.
Alessandro PoliIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Paolo MaiuriDepartment of Molecular Medicine and Medical Biotechnology, University of Naples Federico II, Naples, Italy.
Andrea PalamidessiIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Emanuela FrittoliIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy.
Fabrizio BianchiUnit of Cancer Biomarkers, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
Claudio TripodoIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Human Pathology Section, Department of Health Sciences, University of Palermo School of Medicine, Palermo, Italy.
Kylie J WaltersProtein Processing Section, Center for Structural Biology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Frederick, MD 21702, USA.
Fabio GiavazziDipartimento di Biotecnologie Mediche e Medicina Traslazionale, Università degli Studi di Milano, Segrate, Italy.
Giorgio ScitaIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Dipartimento di Oncologia ed Emato-oncologia, Università degli Studi di Milano, Milan, Italy. Electronic address: giorgio.scita@ifom.eu.
Simona PoloIFOM ETS, The AIRC Institute of Molecular Oncology, Milan, Italy; Dipartimento di Oncologia ed Emato-oncologia, Università degli Studi di Milano, Milan, Italy. Electronic address: simona.polo@ifom.eu.
FIRC Institute of Molecular Oncology · ITUniversity of Milan · ITUniversity of Palermo · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITNational Cancer Institute · USUniversity of Naples Federico II · IT

Funding

Myosin VI: a new ubiquitin receptorZIABC011627 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI WALTERS, KYLIE · 2015 to 2025
$4.6M
Intramural NIH HHS ZIA BC011627
6 · The paper itself

Abstract

Tissue fluidification and collective motility are pivotal in regulating embryonic morphogenesis, wound healing, and tumor metastasis. These processes frequently require that each cell constituent of a tissue coordinates its migration activity and directed motion through the oriented extension of lamellipodium cell protrusions, promoted by RAC1 activity. While the upstream RAC1 regulators in individual migratory cells or leader cells during invasion or wound healing are well characterized, how RAC1 is controlled in follower cells remains unknown. Here, we identify a MYO6-DOCK7 axis essential for spatially restricting RAC1 activity in a planar polarized fashion in model tissue monolayers. The MYO6-DOCK7 axis specifically controls the extension of cryptic lamellipodia required to drive tissue fluidification and cooperative-mode motion in otherwise solid and static carcinoma cell collectives.

Indexed as

BreastPseudopodiaWound HealingMotionCP: Cell biology

Identifiers

PMID37590133
PMCPMC10530600
OpenAlexW4385879866

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.